Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

792987

	registered interest
	date	21/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the timetable is for the negotiations of the next Pharmaceutical Price Regulation Scheme.
	tabling member constituency	Stockton South
	tabling member printed	Dr Paul Williams
	uin	114772
	answer	answer is ministerial correction date of answer 27/11/2017 answer text <p>No decision has been made about the timing of negotiations with industry on medicines pricing arrangements for 2019 onwards. The Department has regular and ongoing dialogue with patient representative groups about medicines pricing and access issues, and all those views will help to inform discussions between the industry and the Department on the new arrangements.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 114773 question first answered 27/11/2017 16:41:41 answering member 4067 label Biography information for Steve Brine
	tabling member	4666 label Biography information for Dr Paul Williams

792988

	registered interest
	date	21/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans his Department has to engage with patient groups on the contents of the next Pharmaceutical Price Regulation Scheme.
	tabling member constituency	Stockton South
	tabling member printed	Dr Paul Williams
	uin	114773
	answer	answer is ministerial correction date of answer 27/11/2017 answer text <p>No decision has been made about the timing of negotiations with industry on medicines pricing arrangements for 2019 onwards. The Department has regular and ongoing dialogue with patient representative groups about medicines pricing and access issues, and all those views will help to inform discussions between the industry and the Department on the new arrangements.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 114772 question first answered 27/11/2017 16:41:42 answering member 4067 label Biography information for Steve Brine
	tabling member	4666 label Biography information for Dr Paul Williams

792989

	registered interest
	date	21/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the success of the Pharmaceutical Price Regulation Scheme in ensuring patients can access the most effective and innovative medicines.
	tabling member constituency	Stockton South
	tabling member printed	Dr Paul Williams
	uin	114774
	answer	answer is ministerial correction date of answer 29/11/2017 answer text <p>Use of innovative medicines in England is reported through the innovation scorecard. The most recent publication was in October 2017 and is available at:</p><p> </p><p><a href="https://digital.nhs.uk/catalogue/PUB30106" target="_blank">https://digital.nhs.uk/catalogue/PUB30106</a></p><p> </p><p>Since 2014, the medicines in the scorecard have changed as new medicines have become available. The scorecard shows that for the 12 months from April 2016 to March 2017, compared to the previous 12 months where comparable data is available, 73% of innovative medicines covered by the scorecard were prescribed more.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2017 14:40:57 answering member 4067 label Biography information for Steve Brine
	tabling member	4666 label Biography information for Dr Paul Williams